GYRE THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Gyre Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Gyre Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $3.26M, a 34.4% decline year-over-year.
  • Gyre Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$67.5M, a 322% decline year-over-year.
  • Gyre Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$67.2M, a 831% decline from 2022.
  • Gyre Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $9.2M.
  • Gyre Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$87.9M, a 53.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$67.5M $3.26M -$1.71M -34.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$65.8M $8.07M +$1.41M +21.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$67.2M -$77.2M -$54.8M -244% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$12.4M -$1.62M +$3.54M +68.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 -$16M $4.97M -$46.6M -90.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $30.6M $6.66M +$21.4M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $9.2M -$22.5M -$2.15M -10.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $11.4M -$5.17M +$20.1M +79.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$8.71M $51.5M +$71.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$80.2M -$14.7M +$7.74M +34.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$87.9M -$20.3M -$1.47M -7.81% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$86.4M -$25.2M -$9.13M -56.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$77.3M -$19.9M -$2.55M -14.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$74.7M -$22.4M -$17.4M -343% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$57.4M -$18.8M -$4.85M -34.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$52.5M -$16.1M -$2.91M -22% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$49.6M -$17.4M -$2.98M -20.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$46.6M -$5.07M +$10.6M +67.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$57.3M -$14M -$2.3M -19.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$55M -$13.2M -$4.85M -58.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$50.1M -$14.4M -$7.27M -102% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$42.9M -$15.7M -$9.04M -135% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$33.8M -$11.7M -$5.86M -100% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$28M -$8.35M -$2.47M -42% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$25.5M -$7.11M -$1.17M -19.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$24.3M -$6.68M -$2.51M -60.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$21.8M -$5.83M -$610K -11.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$21.2M -$5.88M -$166K -2.91% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$21M -$5.94M -$1.03M -20.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$20M -$4.17M +$401K +8.77% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$20.4M -$5.22M -$536K -11.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$19.9M -$5.71M -$1.83M -47% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$18.1M -$4.92M -$2.71M -123% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$15.3M -$4.57M -$1.54M -50.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$13.8M -$4.68M -$2.89M -160% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-09
Q3 2015 -$10.9M -$3.89M -$2.25M -137% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$8.67M -$2.2M +$9K +0.41% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$8.68M -$3.03M -$1.17M -62.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$7.51M -$1.8M +$11.5M +86.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$19M -$1.64M +$11.5M +87.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$30.5M -$2.21M +$10.3M +82.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$40.8M -$1.86M +$6.41M +77.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$47.2M -$13.3M +$2.95M +18.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$50.2M -$13.1M -$5.05M -62.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$45.1M -$12.5M -$26.7M -188% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$18.4M -$8.27M -$10.3M -517% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$8.14M -$16.3M -$6.12M -60.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$2.02M -$8.1M +$1.23M +13.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$3.26M $14.2M +$16.8M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$20.1M $1.99M -$10.3M -83.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$9.75M -$10.1M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$9.33M -$11.7M -486% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$2.57M -$7.54M -152% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 $12.3M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 $2.42M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $4.97M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.